Press Release: ROME Therapeutics : Enara Bio, ROME Therapeutics and Nucleome Therapeutics to Host 2nd Annual Dark Genome Symposium

Oxford, UK, and Boston, Mass. - November 1, 2023 - Enara Bio, ROME Therapeutics and Nucleome Therapeutics, three leading biotechnology companies focused on developing novel medicines driven by insights into the dark genome, today announced that they will host the 2nd Annual Dark Genome Symposium on November 13-14, 2023 at the Francis Crick Institute in London. This event brings together leaders from academia, biotech, pharma and venture capital to continue to build and connect the growing and diverse dark genome community. The overall goal of the symposium, now in its second year, is to deepen our understanding of the dark genome and unlock its potential to enable transformational new therapies for patients.